The ISCHEMIA trial: Implications for non-invasive imaging
Yıl: 2020 Cilt: 24 Sayı: 1 Sayfa Aralığı: 2 - 6 Metin Dili: İngilizce DOI: 10.14744/AnatolJCardiol.2020.82428 İndeks Tarihi: 23-10-2020
The ISCHEMIA trial: Implications for non-invasive imaging
Öz: Coronary artery disease (CAD) is highly prevalent and constitutes the single most common cause of death worldwide. However, the diagnosis of CAD remains challenging. There are two ways to approach the diagnosis of CAD, namely (1) by a functional non-invasive stress test to detect ischemia (stress echocardiography, stress cardiovascular magnetic resonance, single-photon emission computed tomography, positron emis-sion tomography) or (2) by imaging for stenosis visualization (coronary computed tomography angiography or invasive coronary angiography). There are also two approaches for treatment: medical treatment and revascularization. The International Study of Comparative Health Effective-ness with Medical and Invasive Approaches (ISCHEMIA) trial investigated the outcome differences of patients who had moderate to severe ischemia on stress testing and who, after CT angiography, had ruled out left main stenosis and demonstrated at least 1 coronary artery stenosis exceeding 50%. The patients were randomized to an initially conservative treatment versus immediate revascularization. No difference in hard outcomes was found, but angina relief was more effective in the revascularization group. In this article, we explore the implications of the ISCH-EMIA trial for non-invasive testing in suspected CAD. (Anatol J Cardiol 2020; 24: 2-6)
Anahtar Kelime: Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
- 1. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Bren-tano C, et al.; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407-77.
- 2. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with re-vascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial per-fusion single photon emission computed tomography. Circulation 2003; 107: 2900-7.
- 3. Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Alexander KP, Senior R, et al.; ISCHEMIA Research Group. Baseline Characteris-tics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial. JAMA Cardiol 2019; 4: 273-86.
- 4. Berman DS, Kang X, Slomka PJ, Gerlach J, de Yang L, Hayes SW, et al. Underestimation of extent of ischemia by gated SPECT myo-cardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol 2007; 14: 521-8.
- 5. Spertus JA, Jones PG, Maron DJ, O'Brien SM, Reynolds HR, Rosen-berg Y, et al.; ISCHEMIA Research Group. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. N Engl J Med 2020; 382: 1408-19.
- 6. Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, et al.; ISCHEMIA Research Group. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med 2020; 382: 1395-407.
- 7. Bangalore S, Maron DJ, O'Brien SM, Fleg JL, Kretov EI, Briguori C, et al.; ISCHEMIA-CKD Research Group. Management of Coronary Disease in Patients with Advanced Kidney Disease. N Engl J Med 2020; 382: 1608-18.
- 8. Nielsen LH, Ortner N, Nørgaard BL, Achenbach S, Leipsic J, Abdulla J. The diagnostic accuracy and outcomes after coronary com-puted tomography angiography vs. conventional functional testing in patients with stable angina pectoris: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging 2014; 15: 961-71.
- 9. Linde JJ, Kofoed KF, Sørgaard M, Kelbæk H, Jensen GB, Nielsen WB, et al. Cardiac computed tomography guided treatment strat-egy in patients with recent acute-onset chest pain: results from the randomised, controlled trial: CArdiac cT in the treatment of acute CHest pain (CATCH). Int J Cardiol 2013; 168: 5257-62.
- 10. SCOT-HEART Investigators, Newby DE, Adamson PD, Berry C, Boon NA, Dweck MR, et al. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med 2018; 379: 924-33.
- 11. Antman EM, Braunwald E. Managing Stable Ischemic Heart Dis-ease. N Engl J Med 2020; 382: 1468-70.
- 12. Nam CW, Mangiacapra F, Entjes R, Chung IS, Sels JW, Tonino PA, et al.; FAME Study Investigators. Functional SYNTAX score for risk as-sessment in multivessel coronary artery disease. J Am Coll Cardiol 2011; 58: 1211-8.
- 13. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, et al.; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012; 367: 991-1001.
- 14. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah MH, Berman DS, et al. Rationale and design of the CONFIRM (COronary CT Angi-ography EvaluatioN For Clinical Outcomes: An InteRnational Multi-center) Registry. J Cardiovasc Comput Tomogr 2011; 5: 84-92.
| APA | RAKİSHEVA A, MARWAN M, ACHENBACH S (2020). The ISCHEMIA trial: Implications for non-invasive imaging. , 2 - 6. 10.14744/AnatolJCardiol.2020.82428 |
| Chicago | RAKİSHEVA Amina,MARWAN Mohamed,ACHENBACH Stephan The ISCHEMIA trial: Implications for non-invasive imaging. (2020): 2 - 6. 10.14744/AnatolJCardiol.2020.82428 |
| MLA | RAKİSHEVA Amina,MARWAN Mohamed,ACHENBACH Stephan The ISCHEMIA trial: Implications for non-invasive imaging. , 2020, ss.2 - 6. 10.14744/AnatolJCardiol.2020.82428 |
| AMA | RAKİSHEVA A,MARWAN M,ACHENBACH S The ISCHEMIA trial: Implications for non-invasive imaging. . 2020; 2 - 6. 10.14744/AnatolJCardiol.2020.82428 |
| Vancouver | RAKİSHEVA A,MARWAN M,ACHENBACH S The ISCHEMIA trial: Implications for non-invasive imaging. . 2020; 2 - 6. 10.14744/AnatolJCardiol.2020.82428 |
| IEEE | RAKİSHEVA A,MARWAN M,ACHENBACH S "The ISCHEMIA trial: Implications for non-invasive imaging." , ss.2 - 6, 2020. 10.14744/AnatolJCardiol.2020.82428 |
| ISNAD | RAKİSHEVA, Amina vd. "The ISCHEMIA trial: Implications for non-invasive imaging". (2020), 2-6. https://doi.org/10.14744/AnatolJCardiol.2020.82428 |
| APA | RAKİSHEVA A, MARWAN M, ACHENBACH S (2020). The ISCHEMIA trial: Implications for non-invasive imaging. The Anatolian Journal of Cardiology, 24(1), 2 - 6. 10.14744/AnatolJCardiol.2020.82428 |
| Chicago | RAKİSHEVA Amina,MARWAN Mohamed,ACHENBACH Stephan The ISCHEMIA trial: Implications for non-invasive imaging. The Anatolian Journal of Cardiology 24, no.1 (2020): 2 - 6. 10.14744/AnatolJCardiol.2020.82428 |
| MLA | RAKİSHEVA Amina,MARWAN Mohamed,ACHENBACH Stephan The ISCHEMIA trial: Implications for non-invasive imaging. The Anatolian Journal of Cardiology, vol.24, no.1, 2020, ss.2 - 6. 10.14744/AnatolJCardiol.2020.82428 |
| AMA | RAKİSHEVA A,MARWAN M,ACHENBACH S The ISCHEMIA trial: Implications for non-invasive imaging. The Anatolian Journal of Cardiology. 2020; 24(1): 2 - 6. 10.14744/AnatolJCardiol.2020.82428 |
| Vancouver | RAKİSHEVA A,MARWAN M,ACHENBACH S The ISCHEMIA trial: Implications for non-invasive imaging. The Anatolian Journal of Cardiology. 2020; 24(1): 2 - 6. 10.14744/AnatolJCardiol.2020.82428 |
| IEEE | RAKİSHEVA A,MARWAN M,ACHENBACH S "The ISCHEMIA trial: Implications for non-invasive imaging." The Anatolian Journal of Cardiology, 24, ss.2 - 6, 2020. 10.14744/AnatolJCardiol.2020.82428 |
| ISNAD | RAKİSHEVA, Amina vd. "The ISCHEMIA trial: Implications for non-invasive imaging". The Anatolian Journal of Cardiology 24/1 (2020), 2-6. https://doi.org/10.14744/AnatolJCardiol.2020.82428 |
